Unraveling novel survivin mRNA transcripts in cancer cells using an in-house developed targeted high-throughput sequencing approach
- 25 September 2020
- journal article
- research article
- Published by Elsevier BV in Genomics
- Vol. 113 (1), 573-581
- https://doi.org/10.1016/j.ygeno.2020.09.053
Abstract
No abstract availableKeywords
Funding Information
- Bodossaki Foundation
This publication has 65 references indexed in Scilit:
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and explorationBriefings in Bioinformatics, 2012
- Functional consequences of developmentally regulated alternative splicingNature Reviews Genetics, 2011
- Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian CancerClinical Cancer Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Concentration Determination of Nucleic Acids and Proteins Using the Micro-volume Bio-spec Nano SpectrophotometerJournal of Visualized Experiments, 2011
- An Alternative Splicing Network Links Cell-Cycle Control to ApoptosisCell, 2010
- An ESRP-regulated splicing programme is abrogated during the epithelial–mesenchymal transitionThe EMBO Journal, 2010
- Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factorsJournal of Cell Science, 2008
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003